TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX)

Q: What does CUSIP 89854M101 represent in this 13F holders report?

CUSIP 89854M101 is the security identifier for TCRX - TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held TCRX - TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share in Q2 2025?

79 institutional investors reported TCRX - TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 89854M101

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class: Equity / Voting Common Stock, $0.0001 par value per share
Total 13F shares: 35,724,879
Total 13F value: $51,820,655
Share change: -4,382,817
SEC-reported price per share: $1.45
Number of holders: 79
Value change: -$5,881,550
Number of buys: 46
Number of sells: 49
Shares outstanding: 55,838,719

Security key

89854M101

Report period

Q2 2025

Institutions

Top holders

TCRX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 TScan Therapeutics, Inc. SEC filings TScan Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 89854M101

Newer quarter: Q3 2025 Previous quarter: Q1 2025

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of TCRX - TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Lynx1 Capital Management LP

Disclosed value leader

EcoR1 Capital, LLC

Comparable rows

15/15

Latest evidence

30 Jun 2025

13D/G 13F 3/4/5 Lead comparable stake: 15% 13D/G row: Lynx1 Capital Management LP Showing 1-6 of 15 holder rows.

Quick read

Lynx1 Capital Management LP leads the comparable SEC ownership view at 15%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Lynx1 Capital Management LP's linked filing trail.

Comparable ownership Top 5

Lynx1 Capital Management LP 15%

ADAGE CAPITAL PARTNERS GP, L.L.C. 7.1%

K2 HealthVentures Equity Trust LLC 6.9%

Adage Capital Management, L.P. 2.5%

BlackRock, Inc. 1.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Lynx1 Capital Management LP	13D/G 13F Company 13D/G 13F	15%	$11,393,153 7,857,347 shares	+$3,625,000	30 Jun 2025
ADAGE CAPITAL PARTNERS GP, L.L.C.	13D/G 13F Adage Capital Management, L.P. · Company 13D/G 13F	7.1%	$5,600,000 3,500,000 shares	$0	31 Dec 2024
K2 HealthVentures Equity Trust LLC	13D/G 13D/G	6.9%	$5,764,320 3,602,700 shares	$0	31 Dec 2024
Adage Capital Management, L.P.	13D/G 13D/G	2.5%	$1,957,500 1,350,000 shares	$0	30 Jun 2025
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	1.8% from 13D/G	$6,732,789 4,878,833 shares	—	31 Mar 2025
EcoR1 Capital, LLC	3/4/5 13D/G 13F 10%+ Owner · Company 3/4/5 13D/G 13F	1.3% from 13D/G	$24,842,500 5,000,000 shares	—	26 May 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

35,724,879

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

-13

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 value	Q2 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend